{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:39:11Z","timestamp":1759451951556,"version":"build-2065373602"},"reference-count":36,"publisher":"Elsevier BV","issue":"22","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007438","name":"Familien Hede Nielsens Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.vaccine.2019.04.034","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T07:49:43Z","timestamp":1555573783000},"page":"2952-2959","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine \u03b3-herpesvirus 68 infection"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0675-3655","authenticated-orcid":false,"given":"Ditte R.","family":"Boilesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emeline","family":"Ragonnaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henriette","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4976-3813","authenticated-orcid":false,"given":"Anne-Marie C.","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anders","family":"Tolver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1279-304X","authenticated-orcid":false,"given":"Peter J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2019.04.034_b0005","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.virol.2010.12.016","article-title":"Contributions of humoral and cellular immunity to vaccine-induced protection in humans","volume":"411","author":"Amanna","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2019.04.034_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2017.03.003","article-title":"Mucosal vaccination with heterologous viral vectored vaccine targeting subdominant SIV accessory antigens strongly inhibits early viral replication","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"issue":"6135","key":"10.1016\/j.vaccine.2019.04.034_b0015","doi-asserted-by":"crossref","first-page":"1237874","DOI":"10.1126\/science.1237874","article-title":"Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms","volume":"340","author":"Hansen","year":"2013","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.034_b0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.immuni.2015.08.012","article-title":"Magnitude and kinetics of CD8+ T cell activation during hyperacute HIV infection impact viral set point","volume":"43","author":"Ndhlovu","year":"2015","journal-title":"Immunity"},{"issue":"7512","key":"10.1016\/j.vaccine.2019.04.034_b0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/nature13594","article-title":"Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys","volume":"512","author":"Whitney","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.034_b0030","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1365-2796.2008.02054.x","article-title":"Developing an HIV cytotoxic T-lymphocyte vaccine: issues of CD8 T-cell quantity, quality and location","volume":"265","author":"Masopust","year":"2009","journal-title":"J Intern Med"},{"issue":"48","key":"10.1016\/j.vaccine.2019.04.034_b0035","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1016\/j.vaccine.2009.08.104","article-title":"Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load","volume":"27","author":"Hoegh-Petersen","year":"2009","journal-title":"Vaccine"},{"issue":"5403","key":"10.1016\/j.vaccine.2019.04.034_b0040","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.04.034_b0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-immunol-072710-081639","article-title":"Pathogenesis and host control of gammaherpesviruses: lessons from the mouse","volume":"29","author":"Barton","year":"2011","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2019.04.034_b0050","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.4049\/jimmunol.174.8.4972","article-title":"Early establishment of gamma-herpesvirus latency: implications for immune control","volume":"174","author":"Flano","year":"2005","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.034_b0055","doi-asserted-by":"crossref","first-page":"e1000177","DOI":"10.1371\/journal.ppat.1000177","article-title":"A single CD8+ T cell epitope sets the long-term latent load of a murid herpesvirus","volume":"4","author":"Marques","year":"2008","journal-title":"PLoS Pathog"},{"issue":"24","key":"10.1016\/j.vaccine.2019.04.034_b0060","doi-asserted-by":"crossref","first-page":"12205","DOI":"10.1128\/JVI.01463-08","article-title":"The CD8 T-cell response against murine gammaherpesvirus 68 is directed toward a broad repertoire of epitopes from both early and late antigens","volume":"82","author":"Gredmark-Russ","year":"2008","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.034_b0065","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1128\/JVI.02229-09","article-title":"Two kinetic patterns of epitope-specific CD8 T-cell responses following murine gammaherpesvirus 68 infection","volume":"84","author":"Freeman","year":"2010","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.034_b0070","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.celrep.2012.03.009","article-title":"CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection","volume":"1","author":"Sehrawat","year":"2012","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.034_b0075","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"186","author":"Mikkelsen","year":"2011","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.034_b0080","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.180.5.3339","article-title":"MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines","volume":"180","author":"Holst","year":"2008","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.034_b0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CJI.0000000000000153","article-title":"Therapeutic vaccine against primate papillomavirus infections of the cervix","volume":"40","author":"Ragonnaud","year":"2017","journal-title":"J Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2019.04.034_b0090","doi-asserted-by":"crossref","first-page":"e100538","DOI":"10.1371\/journal.pone.0100538","article-title":"Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class II invariant chain","volume":"9","author":"Spencer","year":"2014","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.vaccine.2019.04.034_b0095","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/mt.2014.15","article-title":"Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates","volume":"22","author":"Capone","year":"2014","journal-title":"Mol Ther"},{"issue":"Pt 2","key":"10.1016\/j.vaccine.2019.04.034_b0100","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1099\/vir.0.002105-0","article-title":"Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice","volume":"90","author":"Grujic","year":"2009","journal-title":"J Gen Virol"},{"issue":"115","key":"10.1016\/j.vaccine.2019.04.034_b0105","doi-asserted-by":"crossref","first-page":"115ra2","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.034_b0110","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/sim.6462","article-title":"Analysis of repeated low-dose challenge studies","volume":"34","author":"Nolen","year":"2015","journal-title":"Stat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.034_b0115","doi-asserted-by":"crossref","first-page":"e34884","DOI":"10.1371\/journal.pone.0034884","article-title":"Pre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responses","volume":"7","author":"Steffensen","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.vaccine.2019.04.034_b0120","doi-asserted-by":"crossref","first-page":"e3548","DOI":"10.1371\/journal.pone.0003548","article-title":"Nasal delivery of an adenovirus-based vaccine bypasses pre-existing immunity to the vaccine carrier and improves the immune response in mice","volume":"3","author":"Croyle","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2019.04.034_b0125","doi-asserted-by":"crossref","first-page":"20137","DOI":"10.1038\/srep20137","article-title":"Combined local and systemic immunization is essential for durable T-cell mediated heterosubtypic immunity against influenza A virus","volume":"6","author":"Uddback","year":"2016","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.034_b0130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.virol.2008.08.019","article-title":"Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization","volume":"381","author":"Belyakov","year":"2008","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2019.04.034_b0135","doi-asserted-by":"crossref","first-page":"831","DOI":"10.4049\/jimmunol.177.2.831","article-title":"Stimulation history dictates memory CD8 T cell phenotype: implications for prime-boost vaccination","volume":"177","author":"Masopust","year":"2006","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2019.04.034_b0140","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1128\/CVI.00455-14","article-title":"Multiple low-dose challenges in a rhesus macaque AIDS vaccine trial result in an evolving host response that affects protective outcome","volume":"21","author":"Selinger","year":"2014","journal-title":"Clin Vaccine Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.034_b0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.034_b0150","doi-asserted-by":"crossref","first-page":"e33230","DOI":"10.1371\/journal.pone.0033230","article-title":"Tracking murine gammaherpesvirus 68 infection of germinal center B cells in vivo","volume":"7","author":"Collins","year":"2012","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.vaccine.2019.04.034_b0155","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.1172\/JCI32047","article-title":"Portable flanking sequences modulate CTL epitope processing","volume":"117","author":"Le","year":"2007","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2019.04.034_b0160","doi-asserted-by":"crossref","first-page":"e60245","DOI":"10.1371\/journal.pone.0060245","article-title":"HIV-1 p24(gag) derived conserved element DNA vaccine increases the breadth of immune response in mice","volume":"8","author":"Kulkarni","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.034_b0165","doi-asserted-by":"crossref","first-page":"e18556","DOI":"10.1371\/journal.pone.0018556","article-title":"High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice","volume":"6","author":"Kim","year":"2011","journal-title":"PLoS One"},{"issue":"Pt 6","key":"10.1016\/j.vaccine.2019.04.034_b0170","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1099\/vir.0.82727-0","article-title":"Rapid and sustained CD4+ T-cell-independent immunity from adenovirus-encoded vaccine antigens","volume":"88","author":"Holst","year":"2007","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2019.04.034_b0175","doi-asserted-by":"crossref","first-page":"e87831","DOI":"10.1371\/journal.pone.0087831","article-title":"Quantification of B16 melanoma cells in lungs using triplex Q-PCR \u2013 a new approach to evaluate melanoma cell metastasis and tumor control","volume":"9","author":"Sorensen","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.vaccine.2019.04.034_b0180","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1111\/j.1541-0420.2009.01189.x","article-title":"Assessing vaccine effects in repeated low-dose challenge experiments","volume":"65","author":"Hudgens","year":"2009","journal-title":"Biometrics"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19304852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:32:10Z","timestamp":1759401130000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19304852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":36,"journal-issue":{"issue":"22","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S0264410X19304852"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine \u03b3-herpesvirus 68 infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.04.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}